SIRT5 Directly Inhibits the PI3K/AKT Pathway in Prostate Cancer Cell Lines | Cancer Genomics & Proteomics
Biomedicines | Free Full-Text | Different HSP90 Inhibitors Exert Divergent Effect on Myxoid Liposarcoma In Vitro and In Vivo | HTML
Wonderlands 2015 - Akt Kalender schwarzweiss Foto & Bild | erwachsene, kinder und erwachsene, menschen Bilder auf fotocommunity
Differential effects of AMPK agonists on cell growth and metabolism | Oncogene
Polysaccharide-Based Theranostic Systems for Combined Imaging and Cancer Therapy: Recent Advances and Challenges | ACS Biomaterials Science & Engineering
Frontiers | Regulation of CD4+ T Cell Signaling and Immunological Synapse by Protein Tyrosine Phosphatases: Molecular Mechanisms in Autoimmunity
Frontiers | Interplay Between Calcium and AMPK Signaling in Human Cytomegalovirus Infection
HUMAN PANCREATIC CANCER CELLS UNDERGO PROFOUND METABOLIC REPROGRAMMING TOWARDS CELLULAR STEMNESS AS ADAPTATION TO INHIBITION OF THE AKT PATHWAY | bioRxiv
Phosphorylation of eIF2α triggered by mTORC1 inhibition and PP6C activation is required for autophagy and is aberrant in PP6C-mutated melanoma | Science Signaling
Obesity and cancer, a case for insulin signaling | Cell Death & Disease
MUL1 E3 ligase regulates the antitumor effects of metformin in chemoresistant ovarian cancer cells via AKT degradation
cybercamp-2015/alexaTop1mAXFRcommonSubdomains.fuzz.txt at master · abirtone/cybercamp-2015 · GitHub
Frontiers | Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?
HUMAN PANCREATIC CANCER CELLS UNDERGO PROFOUND METABOLIC REPROGRAMMING TOWARDS CELLULAR STEMNESS AS ADAPTATION TO INHIBITION OF THE AKT PATHWAY | bioRxiv
Metformin: An old drug against old age and associated morbidities - Diabetes Research and Clinical Practice
Nutrient-sensing mTORC1: Integration of metabolic and autophagic signals - Journal of Molecular and Cellular Cardiology
microRNA‐103a Functions as a Mechanosensitive microRNA to Inhibit Bone Formation Through Targeting Runx2 - Zuo - 2015 - Journal of Bone and Mineral Research - Wiley Online Library
The role of selenium in cell survival and its correlation with protective effects against cardiovascular disease: A literature review - ScienceDirect
Mechanistic/mammalian target of rapamycin: Recent pathological aspects and inhibitors - Abdel‐Maksoud - 2019 - Medicinal Research Reviews - Wiley Online Library
The exon-junction complex helicase eIF4A3 controls cell fate via coordinated regulation of ribosome biogenesis and translational output | Science Advances
Inhibition of Polo-like Kinase 1 (Plk1) Enhances the Antineoplastic Activity of Metformin in Prostate Cancer* - Journal of Biological Chemistry
Cancers | Free Full-Text | Molecular and Cellular Mechanisms of Metformin in Cervical Cancer | HTML
HUMAN PANCREATIC CANCER CELLS UNDERGO PROFOUND METABOLIC REPROGRAMMING TOWARDS CELLULAR STEMNESS AS ADAPTATION TO INHIBITION OF THE AKT PATHWAY | bioRxiv
Genomics in acute lymphoblastic leukaemia: insights and treatment implications | Nature Reviews Clinical Oncology
Frontiers | Therapeutic vs. Suprapharmacological Metformin Concentrations: Different Effects on Energy Metabolism and Mitochondrial Function in Skeletal Muscle Cells in vitro
Weight-bearing exercise prevents skeletal muscle atrophy in ovariectomized rats | SpringerLink
Cancer stem cells, plasticity, and drug resistance
Hyperactive Akt-mTOR pathway as a therapeutic target for pain hypersensitivity in Cntnap2-deficient mice - ScienceDirect
